Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Concord, California
  • +73 more
Nov 9, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Not yet recruiting
  • Obesity
  • Overweight
  • Decatur, Georgia
  • +35 more
Oct 11, 2023

Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • +4 more
  • Phoenix, Arizona
  • +168 more
Jul 10, 2023

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Obesity, Obese, Overweight or Obesity Trial in New Zealand (biological, drug, other)

Recruiting
  • Obesity
  • +2 more
  • Bimagrumab
  • +2 more
  • Anniston, Alabama
  • +23 more
Feb 1, 2023

Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Obesity
  • Birmingham, Alabama
  • +253 more
Jan 24, 2023

Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Not yet recruiting
  • Overweight
  • +2 more
  • Concord, California
  • +147 more
Jan 24, 2023

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

Obesity Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +106 more
Jan 24, 2023

Obesity Trial in Worldwide (semaglutide 2.4 mg, semaglutide 2.4 mg ())

Active, not recruiting
  • Obesity
  • semaglutide 2.4 mg
  • semaglutide 2.4 mg (placebo)
  • Montgomery, Alabama
  • +64 more
Jan 24, 2023

Overweight, Obesity Trial (Semaglutide, Placebo semaglutide)

Active, not recruiting
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +21 more
Jan 24, 2023

Obesity Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +225 more
Jan 24, 2023

Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

Recruiting
  • Obesity
  • Overweight
  • Gilbert, Arizona
  • +695 more
Jan 18, 2023

Obesity Trial in Worldwide (Semaglutide 2.4 mg, Placebo)

Active, not recruiting
  • Obesity
  • Semaglutide 2.4 mg
  • Placebo
  • Calgary, Alberta, Canada
  • +21 more
Mar 22, 2022

Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Completed
Has Results
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +40 more
Mar 21, 2022

Overweight, Obesity Trial in Worldwide (NNC0174-0833, Placebo (NNC0174-0833), Liraglutide 3.0 mg)

Completed
  • Overweight
  • Obesity
  • Anaheim, California
  • +53 more
Feb 24, 2022

Bariatric Surgery, Chronic Kidney Diseases, Obesity Trial in Hamilton (Bariatric Surgery + Medical Management of CKD., Medical

Not yet recruiting
  • Bariatric Surgery
  • +2 more
  • Bariatric Surgery + Medical Management of CKD.
  • Medical Management for CKD
  • Hamilton, Ontario, Canada
    St. Joseph's Healthcare Hamilton
Feb 13, 2022

Obesity, Overweight Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Obesity
  • Overweight
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +50 more
Jan 26, 2022

Heart Disease, Cardiovascular Disease, Sedentary Lifestyle Trial in United States (Group 1 (Intervention), Group 2 (Delayed

Completed
  • Heart Disease
  • +4 more
  • Group 1 (Intervention)
  • Group 2 (Delayed intervention)
  • Clyde, New York
  • +12 more
Jan 3, 2022

Overweight, Obesity Trial in Canada, United States (Hockey FIT Program (Immediate Delivery))

Active, not recruiting
  • Overweight
  • Obesity
  • Hockey FIT Program (Immediate Delivery)
  • Flint, Michigan
  • +39 more
Nov 26, 2021

Rectal Cancer, Obesity Trial in Hamilton (Very Low Energy Diet)

Not yet recruiting
  • Rectal Cancer
  • Obesity
  • Very Low Energy Diet
  • Hamilton, Ontario, Canada
    St. Joseph's Healthcare
Sep 8, 2021

Type II Diabetes, Obesity Trial in Hamilton (PolyGlycopleX® - PGX®, Rice Flour ())

Terminated
  • Type II Diabetes Mellitus
  • Obesity
  • PolyGlycopleX® - PGX®
  • Rice Flour (placebo)
  • Hamilton, Ontario, Canada
    Wharton Medical Clinic and Weight Management Centre
Feb 8, 2021

Cancer, Venous Thromboembolism, Obesity Trial in Canada (Dalteparin)

Recruiting
  • Cancer
  • +2 more
  • Dalteparin
  • Edmonton, Alberta, Canada
  • +4 more
Jan 12, 2021

Remote vs In Person Weight Loss Study

Recruiting
  • Obesity
  • Remote Behaviour Modification Program
  • In Person Behaviour Modification Program
  • Hamilton, Ontario, Canada
    St Joseph's Healthcare Hamilton
Dec 1, 2020

Obesity Trial in Canada (Contrave 8Mg-90Mg Extended-Release Tablet, Placebo)

Unknown status
  • Obesity
  • Contrave 8Mg-90Mg Extended-Release Tablet
  • Placebo
  • Guelph, Ontario, Canada
  • +3 more
Oct 9, 2020